A2AR	Adenosine A2A receptor
ADHD	Attention deficit hyperactivity disorder
AlphaScreen	Amplified luminescent proximity homogeneous assay screen (based on luminescent oxygen channeling immunoassay)
BBB	Blood–brain barrier
BHT-920	5,6,7,8-Tetrahydro-6-(2-propen-1-yl)-4H-thiazolo[4,5-d]azepin-2-amine dihydrochloride
BiFC	Bimolecular fluorescence complementation
BRET	Bioluminescence resonance energy transfer
CGS21680	2-[p-(2-carboxyethyl)phenethylamino]-5’- N-ethylcarboxamido-adenosine
CNS	Central nervous system
CSC	8-(3-Chlorostyryl)caffeine
D2R	Dopamine D2 receptor
DMFP	Desmethoxyfallypride
DMPX	3,7-Dimethyl-1-propargylxanthine
FCP	Fluoroclebopride
FEBF	Fluorethyl-2,3-dihydrobenzofuran
FESP	Fluoroethyl-spiperone
FPE	Fluoropropyl-epidepride
FPSP	Fluoropropyl-spiperone
FRET	Fluorescence resonance energy transfer
MABN	2,3-dimethoxy-N-[9-(4-fluorobenzyl)-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide
MBP	2,3-dimethoxy-N-[1-(4-fluorobenzyl)piperidin4yl]benzamide
MNPA	Methoxy-N-n-propylnorapomorphine
MSN	Medium spiny neuron
MECA	5′-(N-methyl)carboxamido-adenosine
NECA	5’-(N-ethyl)carboxamido-adenosine
NMSP	N-methyl-spiperone
NPA	N-n-propylnorapomorphine
PANNS	Positive and Negative Syndrome Scale
PIA	N6-R-phenylisopropyladenosine
PPHT	(+/-)-2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin
TMSX	[7-methyl-11C]-(E)-8-(3,4,5-trimethoxystyryl)-1,3,7-trimethylxanthine
XCC	8-(p-carboxymethyloxy)phenyl-1,3 dipropylxanthine